323990.KQ
Price:
$4395
Market Cap:
$101.85B
Established in 2010, Vaxcell-Bio Therapeutics Co., Ltd. specializes in the research, development, and commercialization of immune cell-based therapies designed to treat cancer, primarily operating within South Korea. The company's main base of operations is located in Hwasun-eup, South Korea.
Industry
Biotechnology
IPO Date
2020-09-22
Stock Exchange
KOE
Ticker
323990.KQ
According to Vaxcell-Bio Therapeutics Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 97.83B. This represents a change of -45.91% compared to the average of 180.86B of the last 4 quarters.
The mean historical Enterprise Value of Vaxcell-Bio Therapeutics Co., Ltd. over the last ten years is 296.93B. The current 97.83B Enterprise Value has changed 3.19% with respect to the historical average. Over the past ten years (40 quarters), 323990.KQ's Enterprise Value was at its highest in in the December 2022 quarter at 868.09B. The Enterprise Value was at its lowest in in the June 2026 quarter at 114.40B.
Average
296.93B
Median
233.82B
Minimum
-9563353293.32
Maximum
573.42B
Discovering the peaks and valleys of Vaxcell-Bio Therapeutics Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.26%
Maximum Annual Enterprise Value = 573.42B
Minimum Annual Increase = -5796.22%
Minimum Annual Enterprise Value = -9563353293.32
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 228.10B | -2.44% |
| 2024 | 233.82B | -50.53% |
| 2023 | 472.67B | -17.57% |
| 2022 | 573.42B | 5.26% |
| 2021 | 544.75B | -5796.22% |
| 2020 | -9563353293.32 | -127.10% |
The current Enterprise Value of Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
311.53B
5-year avg
410.55B
10-year avg
296.93B
Vaxcell-Bio Therapeutics Co., Ltd.’s Enterprise Value is less than Hana Technology Co., Ltd. (201.12B), less than TOP MATERIAL Co., Ltd (143.54B), less than LOT VACUUM Co., Ltd. (156.39B), less than JEIO Co., Ltd. (219.67B), less than T-Robotics.Co.,Ltd. (332.25B), greater than LabGenomics Co., Ltd. (95.98B), less than DRTECH Corporation (141.92B), less than Gc Cell Corp. (335.11B), greater than Dongkuk Structures & Construction Company Limited (81.00B), greater than APS Innovation Co., Ltd. (15.82B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 201.12B | $126.40B | |
| 143.54B | $82.58B | |
| 156.39B | $202.98B | |
| 219.67B | $160.43B | |
| 332.25B | $335.21B | |
| 95.98B | $42.76B | |
| 141.92B | $64.86B | |
| 335.11B | $228.26B | |
| 81.00B | $89.90B | |
| 15.82B | $79.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxcell-Bio Therapeutics Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vaxcell-Bio Therapeutics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vaxcell-Bio Therapeutics Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)?
What is the 3-year average Enterprise Value for Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)?
What is the 5-year average Enterprise Value for Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)?
How does the current Enterprise Value for Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ) compare to its historical average?